Skip to content
10-Q

Quarterly Report

Marker Therapeutics, Inc. MRKR

0001104659-25-111502

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 6, 2025 16.67M sh
Shares Diluted Q3 2025 · Sep 30, 2025 16.76M sh
Shares Diluted Q3 2025 · Sep 30, 2025 13.96M sh
Shares Diluted Q3 2025 · Sep 30, 2024 8.92M sh
Shares Diluted Q3 2025 · Sep 30, 2024 8.91M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$10.11M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$6.21M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $17.59M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $19.19M
Stockholders Equity Q3 2025 · Sep 30, 2025 $18.39M
Stockholders Equity Q3 2025 · Jun 30, 2025 $10.49M
Stockholders Equity Q3 2025 · Dec 31, 2024 $18.56M
Stockholders Equity Q3 2025 · Sep 30, 2024 $7.45M
Stockholders Equity Q3 2025 · Jun 30, 2024 $9.7M
Stockholders Equity Q3 2025 · Dec 31, 2023 $14.05M
Current Liabilities Q3 2025 · Sep 30, 2025 $3.35M
Current Liabilities Q3 2025 · Dec 31, 2024 $3.46M
Total Liabilities Q3 2025 · Sep 30, 2025 $3.35M
Total Liabilities Q3 2025 · Dec 31, 2024 $3.46M
Current Assets Q3 2025 · Sep 30, 2025 $21.73M
Current Assets Q3 2025 · Dec 31, 2024 $22.02M
Total Assets Q3 2025 · Sep 30, 2025 $21.73M
Total Assets Q3 2025 · Dec 31, 2024 $22.02M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.12
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.75
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.26
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.77
Eps Basic Q3 2025 · Sep 30, 2025 −$0.12
Eps Basic Q3 2025 · Sep 30, 2025 −$0.75
Eps Basic Q3 2025 · Sep 30, 2024 −$0.26
Eps Basic Q3 2025 · Sep 30, 2024 −$0.77
Sga Expense Q3 2025 · Sep 30, 2025 $1.02M
Sga Expense Q3 2025 · Sep 30, 2025 $3.34M
Sga Expense Q3 2025 · Sep 30, 2024 $854.68K
Sga Expense Q3 2025 · Sep 30, 2024 $3.21M
Rd Expense Q3 2025 · Sep 30, 2025 $2.35M
Rd Expense Q3 2025 · Sep 30, 2025 $9.66M
Rd Expense Q3 2025 · Sep 30, 2024 $3.47M
Rd Expense Q3 2025 · Sep 30, 2024 $8.38M
Net Income Q3 2025 · Sep 30, 2025 −$2M
Net Income Q3 2025 · Sep 30, 2025 −$10.46M
Net Income Q3 2025 · Sep 30, 2024 −$2.31M
Net Income Q3 2025 · Sep 30, 2024 −$6.89M
Operating Income Q3 2025 · Sep 30, 2025 −$2.14M
Operating Income Q3 2025 · Sep 30, 2025 −$11.01M
Operating Income Q3 2025 · Sep 30, 2024 −$2.4M
Operating Income Q3 2025 · Sep 30, 2024 −$7.26M